Dr Dario Carugo

Research summary

Dario’s research focuses in three complementary areas:

(1) Ultrasound-mediated Therapies. The non-specific action of systemic therapeutic agents frequently results in reduced treatment effectiveness and further detriment to patient health. Ultrasound responsive micro- and nano-carriers provide a dynamic means of drug delivery, with high temporal and spatial specificity, whilst limiting adverse systemic side-effects. In our group, we engineer ultrasound-responsive drug carriers for application in the treatment of bone fractures or as bioactive adjuvants in the treatment of bacterial biofilms in chronic wounds. We also develop bio-physical models to investigate the efficacy of these agents under conditions that mimic their end-point application.  

(2) Interventional Medicine. When assessing the efficacy of new therapeutic agents and medical devices, it is important that real-life conditions are replicated accurately before in vivo testing. In our group, we develop biomimetic and fluidic models to evaluate the pharmacokinetics and flow behaviour of therapeutic agents, including chemo-embolic microparticles and sclerosing foams. We also design computational and experimental models to investigate the role of flow dynamics on the formation of crystalline biofilms in endourological devices (i.e. ureteric stents and catheters).

(3) Scalable and Cost-Effective Flow Reactors. Microfluidic reactor technology has emerged as a valuable tool for organic and inorganic synthesis. There are however challenges that may limit widespread adoption of microfluidic reactors, including high manufacturing costs, limited lifetime, and low production rates. To overcome these limitations, we develop microfluidic platforms with improved cost-effectiveness, ease of use, and utility in non-specialised environments. We use numerical and experimental methods to design and manufacture a range of reactor technologies, including up-scaled (millifluidic) reactors, ultrasound-activated (sonofluidic) mixers, and reactors-in-a-centrifuge. We employ these devices to produce inorganic nanoparticles and drug delivery systems, including liposomes, niosomes, polymeric micelles, and ultrasound contrast agents.

Education

Other undergraduate qualification (including professional), BSc in Biomedical Engineering |

Other Postgraduate qualification (including professional), MSc in Biomedical Engineering |

Other Postgraduate qualification (including professional), Fellow of the Higher Education Academy (FHEA) |

Publications

Show more publications